Site-specific sulfations regulate the physicochemical properties of papillomavirus-heparan sulfate interactions for entry.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
04 Oct 2024
Historique:
medline: 4 10 2024
pubmed: 4 10 2024
entrez: 4 10 2024
Statut: ppublish

Résumé

Certain human papillomaviruses (HPVs) are etiological agents for several anogenital and oropharyngeal cancers. During initial infection, HPV16, the most prevalent cancer-causing type, specifically interacts with heparan sulfates (HSs), not only enabling initial cell attachment but also triggering a crucial conformational change in viral capsids termed structural activation. It is unknown, whether these HPV16-HS interactions depend on HS sulfation patterns. Thus, we probed potential roles of HS sulfations using cell-based functional and physicochemical assays, including single-molecule force spectroscopy. Our results demonstrate that N-sulfation of HS is crucial for virus binding and structural activation by providing high-affinity sites, and that additional 6O-sulfation is required to mechanically stabilize the interaction, whereas 2O-sulfation and 3O-sulfation are mostly dispensable. Together, our findings identify the contribution of HS sulfation patterns to HPV16 binding and structural activation and reveal how distinct sulfation groups of HS synergize to facilitate HPV16 entry, which, in turn, likely influences the tropism of HPVs.

Identifiants

pubmed: 39365863
doi: 10.1126/sciadv.ado8540
doi:

Substances chimiques

Heparitin Sulfate 9050-30-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eado8540

Auteurs

Fouzia Bano (F)

Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.
Umeå Centre for Microbial Research, Umeå University, Umeå, Sweden.

Laura Soria-Martinez (L)

Institute of Cellular Virology, ZMBE, University of Münster, Münster, Germany.
Research Group "ViroCarb: Glycans controlling non-enveloped virus infections" (FOR2327), Coordinating University of Tübingen, Germany.

Dominik van Bodegraven (D)

Institute of Cellular Virology, ZMBE, University of Münster, Münster, Germany.
Research Group "ViroCarb: Glycans controlling non-enveloped virus infections" (FOR2327), Coordinating University of Tübingen, Germany.

Konrad Throsteinsson (K)

Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.
Umeå Centre for Microbial Research, Umeå University, Umeå, Sweden.

Anna M Brown (AM)

Department of Chemistry, Davidson College, Davidson, NC, USA.

Ines Fels (I)

Institute of Cellular Virology, ZMBE, University of Münster, Münster, Germany.

Nicole L Snyder (NL)

Department of Chemistry, Davidson College, Davidson, NC, USA.

Marta Bally (M)

Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.
Umeå Centre for Microbial Research, Umeå University, Umeå, Sweden.

Mario Schelhaas (M)

Institute of Cellular Virology, ZMBE, University of Münster, Münster, Germany.
Research Group "ViroCarb: Glycans controlling non-enveloped virus infections" (FOR2327), Coordinating University of Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH